Our experts
The people behind the analysis
APEDRA's reviews are produced by an editorial team of clinicians, pharmacology researchers and analysts.
Dr A. Whitfield
PhD (Pharmacology)
Editorial Director
Adjunct research fellow, School of Medical Sciences, University of Sydney
Pharmacology & evidence synthesis
Leads review methodology and sign-off on all published analysis, with a background in systematic review of endocrine pharmacology.
Conflicts of interest: No financial interests in any vendor, supplement company or compounding pharmacy. No industry consultancy income.
Dr R. Okafor
MBBS, FRACP (Endocrinology)
Clinical Reviewer
Consultant endocrinologist, tertiary teaching hospital, Melbourne
Endocrinology
Reviews hormonal and metabolic content, including suppression, recovery protocols and monitoring recommendations.
Conflicts of interest: Salaried clinical appointment only. No speaker fees, advisory boards or industry funding to declare.
Dr S. Marchetti
MBBS, FACSP
Clinical Reviewer
Sport & exercise medicine physician, private practice, Brisbane
Sports & exercise medicine
Assesses performance claims against measured outcomes and advises on cardiovascular screening guidance.
Conflicts of interest: No equity or commercial relationship with any assessed vendor. Occasional paid medico-legal reporting, unrelated to PEDs.
E. Nakamura
MSc (Drug Discovery & Development)
Research Analyst
PhD candidate, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University
SARMs & small-molecule literature
Maintains the SARM evidence base, tracking new trials, case reports and analytical purity studies.
Conflicts of interest: Research supported by a university stipend only. No industry funding or vendor relationships.
T. Kowalski
MSc (Biochemistry)
Research Analyst
Research officer, peptide therapeutics laboratory, University of Queensland
Peptides & growth factors
Covers secretagogue and peptide literature, with attention to the gap between preclinical and human evidence.
Conflicts of interest: Employer receives no funding from any vendor assessed by APEDRA. No personal financial interests to declare.
M. Devereaux
BPharm (Hons), MPS
Analytical Consultant
Practising pharmacist, analytical quality consultancy, Perth
Product quality & purity testing
Interprets certificates of analysis and third-party testing data used in our vendor assessments.
Conflicts of interest: Consultancy has no contracts with any assessed vendor. No income derived from the sale of any product reviewed.
J. Hartley
BSc (Hons), MPH candidate
Community Research Lead
Independent harm-reduction researcher, Sydney
Anecdotal report aggregation
Collects and categorises community reports, keeping them clearly separated from peer-reviewed findings.
Conflicts of interest: No commercial affiliations. Community report data is collected without vendor involvement or sponsorship.
C. Anand
LLB, BCom
Vendor Assessment Lead
Consumer policy analyst, independent, Melbourne
Policy & marketplace review
Applies the published vendor methodology and manages correction requests from suppliers.
Conflicts of interest: Has never held employment, equity or commission arrangements with any vendor on the assessment list.
Editorial standards
What independence means here
- No author, reviewer or analyst holds a financial interest in any vendor we assess.
- Every claim of effect is traced to a named, citable study or explicitly labelled as anecdotal.
- Where evidence is preclinical or absent, we say so rather than filling the gap with inference.
- Corrections are published openly with the reason for the change.